CapsoVision, Inc

CV · Nasdaq · SIC 3845: Electromedical & Electrotherapeutic Apparatus
19
SEC Filings

Business Summary

PART I We are a global commercial-stage medical technology company focused on creating diagnostic and screening products to identify abnormalities of the GI tract. We develop advanced imaging and AI technologies in creating such products while maximizing the flexibility, convenience, profitability, and safety of patient care. We are a Delaware company, incorporated in 2005. Our corporate headquarters is located in Saratoga, California. Currently, our GI-tract capsule endoscopy solution comprises...

Next Earnings

Q2 FY2026 — expected 2026-09-12

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCVdiscussed_in_filing Artificial Intelligence
topic_mentionCVdiscussed_in_filing Cybersecurity
topic_mentionCVdiscussed_in_filing Trusted Computing
topic_mentionCVdiscussed_in_filing Blockchain & Crypto
topic_mentionCVdiscussed_in_filing Capital Expenditure
topic_mentionCVdiscussed_in_filing Supply Chain
topic_mentionCVdiscussed_in_filing Regulation
topic_mentionCVdiscussed_in_filing Healthcare & Bio
topic_mentionCVdiscussed_in_filing Platform & Ecosystem
topic_mentionCVdiscussed_in_filing Artificial Intelligence
topic_mentionCVdiscussed_in_filing Cybersecurity
topic_mentionCVdiscussed_in_filing Trusted Computing
topic_mentionCVdiscussed_in_filing Blockchain & Crypto
topic_mentionCVdiscussed_in_filing Capital Expenditure
topic_mentionCVdiscussed_in_filing Supply Chain
topic_mentionCVdiscussed_in_filing Regulation
topic_mentionCVdiscussed_in_filing Healthcare & Bio
topic_mentionCVdiscussed_in_filing Platform & Ecosystem
topic_mentionCVdiscussed_in_filing Artificial Intelligence
topic_mentionCVdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001378325-26-000010EDGAR96K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001378325-25-000040EDGAR59K words
2025-08-142025-06-300001378325-25-000010EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001378325-26-000008EDGAR3K words
2026-03-200001378325-26-000004EDGAR—
2026-03-130001378325-26-000002EDGAR—
2025-12-290001378325-25-000043EDGAR—
2025-11-130001378325-25-000039EDGAR—
2025-11-100001378325-25-000031EDGAR—
2025-11-030001378325-25-000027EDGAR—
2025-09-260001378325-25-000022EDGAR—
2025-09-030001378325-25-000018EDGAR—
2025-08-140001378325-25-000008EDGAR—

19 total filings indexed. 6 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ADMT — ADM TRONICS UNLIMITED, INC. AXGN — Axogen, Inc. BLFS — BIOLIFE SOLUTIONS INC CNMD — CONMED Corp CBLL — Ceribell, Inc. EDAP — EDAP TMS SA ENDV — ENDONOVO THERAPEUTICS, INC. NDRA — ENDRA Life Sciences Inc.

Company Identity

CIK0001378325
TickerCV
ExchangeNasdaq
SIC3845: Electromedical & Electrotherapeutic Apparatus
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: bb2c25744270a875e21a58559ed6cab96755247e4db01f93f8d733c51d47816d
parent: 7683071152188805dc0f5341abc5372e8593285c516054e090159eaf2164ae10
content hash: 8202678342437669382fb7320d122ebda3211aaa05b65678a6949fd940146af9
signed: 2026-04-13T04:44:33.784Z
sources: 3 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf